An Animated Functional Data Analysis Interface to Cluster Rapid Lung Function Decline and Enhance Center-Level Care in Cystic Fibrosis.

Journal of Healthcare Engineering
Jesse PrattRhonda D Szczesniak

Abstract

Identifying disease progression through enhanced decision support tools is key to chronic management in cystic fibrosis at both the patient and care center level. Rapid decline in lung function relative to patient level and center norms is an important predictor of outcomes. Our objectives were to construct and utilize center-level classification of rapid decliners to develop an animated dashboard for comparisons within patients over time, multiple patients within centers, or between centers. A functional data analysis technique known as functional principal components analysis was applied to lung function trajectories from 18,387 patients across 247 accredited centers followed through the United States Cystic Fibrosis Foundation Patient Registry, in order to cluster patients into rapid decline phenotypes. Smaller centers (<30 patients) had older patients with lower baseline lung function and less severe rates of decline and had maximal decline later, compared to medium (30-150 patients) or large (>150 patients) centers. Small centers also had the lowest prevalence of early rapid decliners (17.7%, versus 24% and 25.7% for medium and large centers, resp.). The animated functional data analysis dashboard illustrated clustering an...Continue Reading

References

Feb 1, 1993·Pediatric Pulmonology·X WangB G Ferris
Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine·J L HankinsonK B Fedan
Feb 24, 2001·American Journal of Epidemiology·T G LiouB C Marshall
Jul 24, 2007·The Journal of Pediatrics·Michael W KonstanUNKNOWN Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis
Apr 30, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Philip M Farrell
Aug 2, 2008·American Journal of Respiratory and Critical Care Medicine·Elliott C DasenbrookMichael P Boyle
May 14, 2010·American Journal of Respiratory and Critical Care Medicine·Don B SandersChristopher H Goss
May 18, 2010·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Theodore G LiouJeffrey S Wagener
Oct 6, 2010·Archives of Pediatrics & Adolescent Medicine·Gary L McPhailMichael Seid
Nov 19, 2010·The New England Journal of Medicine·Frank J AccursoBonnie W Ramsey
Apr 6, 2011·Pediatric Pulmonology·Nathan C KraynackJohn T McBride
Jan 14, 2012·Pediatric Pulmonology·Stacy L VandenbrandenUNKNOWN Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis
Jan 19, 2013·BMC Medical Research Methodology·Kathrine Frey FrøslieMarit B Veierød
Jun 28, 2013·Annals of the American Thoracic Society·Rhonda D VanDykeMichael Seid
Oct 10, 2013·Annals of Epidemiology·Rhonda D SzczesniakJohn P Clancy
Dec 18, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Sanja StanojevicDiana Bilton
Sep 22, 2015·The Journal of Pediatrics·Wayne J MorganUNKNOWN Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis
Apr 15, 2016·Annals of the American Thoracic Society·Emily A KnappBruce C Marshall
Jan 25, 2017·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Rhonda SzczesniakNicole Mayer-Hamblett
Apr 16, 2017·American Journal of Respiratory and Critical Care Medicine·Rhonda D SzczesniakJohn P Clancy
Apr 26, 2017·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·D R VanDevanterUNKNOWN STOP Study Group
Dec 2, 2017·American Journal of Respiratory and Critical Care Medicine·Bruce H CulverUNKNOWN ATS Committee on Proficiency Standards for Pulmonary Function Laboratories
Jan 10, 2018·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Ruth H KeoghDiana Bilton
May 26, 2018·Orphanet Journal of Rare Diseases·Kathryn A SabadosaBruce C Marshall
Oct 20, 2018·The New England Journal of Medicine·Dominic KeatingUNKNOWN VX16-445-001 Study Group
Dec 10, 2019·Statistics in Medicine·Rhonda D SzczesniakJohn P Clancy

❮ Previous
Next ❯

Software Mentioned

SAS
ODS
FPCA
ODS PRINTER
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.